4.19
Niagen Bioscience Inc (NAGE) 最新ニュース
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results - BioSpace
Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs (UPDATED) - Benzinga
Niagen Bioscience reaffirms 10%-15% 2026 growth outlook while increasing marketing spend expectations - MSN
Niagen Bioscience Earnings Call Highlights Growth Push - TipRanks
Niagen Bioscience Q1 2026 slides: e-commerce surges 14% amid transition - Investing.com
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Niagen Bioscience Reports Q1 Results, Updates 2026 Outlook - TipRanks
Niagen (NAGE) Q1 2026 Earnings Call Transcript - AOL.com
Earnings call transcript: Niagen Bioscience Q1 2026 sees growth in e-commerce - Investing.com
Niagen Bioscience (NASDAQ:NAGE) Shares Slide After Q1 Earnings Miss and Spending Guidance - ChartMill
Niagen Bioscience: Q1 Earnings Snapshot - marketscreener.com
[8-K] Niagen Bioscience, Inc. Reports Material Event - Stock Titan
Segment sale lifts Niagen Bioscience (Nasdaq: NAGE) Q1 2026 profit - Stock Titan
Niagen Bioscience Is Maintained at Buy by Canaccord Genuity - Moomoo
CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Niagen Bioscience Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView
Niagen Bioscience (NAGE) Launches Telehealth Platform for Home D - GuruFocus
Niagen Bioscience launches telehealth platform with at-home kit - Investing.com UK
Niagen Bioscience Enters Telehealth With At-Home NAD+ Precursor Injection Kits - Athletech News
Niagen Bioscience launches telehealth platform with at-home kit By Investing.com - Investing.com India
Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering - 巴士的報
NAGE Technical Analysis | Trend, Signals & Chart Patterns | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience (NAGE) outlines 2026 director elections, auditor ratification and executive pay vote - Stock Titan
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus - BioSpace
Insider Decision Unfolding At Niagen Bioscience: Robert Fried Exercises Options, Resulting In $46K - Benzinga
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™ - Yahoo Finance
Insider Decision Unfolding At Niagen Bioscience: CEO Robert Fried Exercises Options(CORRECTED) - Benzinga
Notable Insider Move: Robert Fried Takes Part In Options Exercise At Niagen Bioscience, Resulting In $45K - Benzinga
Niagen Bioscience (NAGE) CEO adds 20,000 shares via option exercise - Stock Titan
Wall Street Zen Downgrades Niagen Bioscience (NASDAQ:NAGE) to Hold - MarketBeat
Niagen Bioscience Secures USP Monograph and Extends NR Patent Protection - HarianBasis.co
NAGE (Niagen Bioscience Inc.) reports solid Q4 2025 EPS beat and nearly 30 percent year over year revenue growth, stock rises modestly.Investment Community Signals - Cổng thông tin điện tử tỉnh Lào Cai
Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 - BioSpace
Niagen Bioscience (NAGE) Well-Positioned With Recent Dietary Supplement Ingredient Monograph - Yahoo Finance
Niagen Bioscience (NAGE) price target decreased by 13.92% to 13.87 - MSN
Is Niagen Bioscience (NAGE) stock losing bullish momentum | Q4 2025: EPS Exceeds ExpectationsCommunity Buy Signals - Cổng thông tin điện tử Tỉnh Sơn La
How The Niagen Bioscience (NAGE) Story Is Shifting With New Q4 Models And Injectables - Yahoo Finance
Niagen Bioscience Stock Short Interest Report | NASDAQ:NAGE - Benzinga
Is Niagen Bioscience (NAGE) stock holding under pressure (Near Lows) 2026-04-20Social Momentum Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a Potential 187.53% Upside in the Biotechnology Sector - DirectorsTalk Interviews
Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration - Sahm
NAGE Stock Price, Quote & Chart | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Niagen Bioscience: How Its Shift To Telehealth Makes It A Strong Buy (NASDAQ:NAGE) - Seeking Alpha
Niagen: High-Quality Growth At A Fair Price (NASDAQ:NAGE) - Seeking Alpha
Value Recap: Will Niagen Bioscience Inc stock go up in YEAR2026 Setups & Free High Return Stock Watch Alerts - baoquankhu1.vn
Q3 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
大文字化:
|
ボリューム (24 時間):